Prognostic significance of peritoneal washing cytology in patients with gastric cancer

British Journal of Surgery

Volumn 99, Issue 3, 2012, Pages 397-403

  Lee, S D ^a   Ryu, K W ^b   Eom, B W ^b   Lee, J H ^b   Kook, M C ^b   Kim, Y W ^b  

^a Seoul National University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASCITES FLUID; CANCER INVASION; FEMALE; GASTRECTOMY; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PERITONEUM LAVAGE; PERITONEUM TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL; TUMOR SEEDING;

AGED; ASCITIC FLUID; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM SEEDING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84856411965     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7812     Document Type: Article

References (33)

1. Department of Population Tendency of Korea National Statistical Office. Mortality and the Cause of Death in 2007. Korea National Statistical Office: Seoul, 2008.
2. Ministry for Health, Welfare, and Family Affairs. Cancer Incidence in 2006-2007. National Cancer Information Centre: Seoul, 2009.
3. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
4. Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, et al., Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 2009; 21: 855-860.
5. Shimoyama S, Seto Y, Yasuda H, Mafune K, Kaminishi M,. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg 2005; 29: 58-65. (Pubitemid 40576490)
6. Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, et al., A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006; 9: 262-270. (Pubitemid 44846548)
7. Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, et al., Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 2005; 241: 232-237.
8. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al., MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
9. Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al., Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 2006; 9: 51-66. (Pubitemid 43890701)
10. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. American Joint Committee on Cancer (AJCC) Cancer Staging Manual (7th edn). Springer: Chicago, 2010.
11. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, et al., Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg 1999; 178: 256-262. (Pubitemid 29475109)
12. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ,. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996; 83: 672-674. (Pubitemid 26163552)
13. Homma Y, Ushida S, Yamada M, Kobayashi H, Suzuki K,. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients. Ann Surg Oncol 2010; 17: 455-460.
14. Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE,. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol 2010; 17: 3173-3180.
15. La Torre M, Ferri M, Giovagnoli MR, Sforza N, Cosenza G, Giarnieri E, et al., Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J Surg Oncol 2010; 36: 982-986.
16. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al., Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008; 15: 2684-2691.
17. Green FL, Balch CM, Fleming ID, Page DL, Haller DG, Morrow M,. AJCC Cancer Staging Manual: TNM classification of Malignant Tumors (6th edn). Springer: New York, 2002.
18. Iriyama K, Asakawa T, Koike H, Nishiwaki H, Suzuki H,. Is extensive lymphadenectomy necessary for surgical treatment of intramucosal carcinoma of the stomach? Arch Surg 1999; 124: 309-311.
19. Laurén T,. The two histologic main types of gastric carcinoma. Acta Pathol Microbiol Scand 1965; 64: 34-35.
20. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D,. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005; 12: 347-353.
21. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al., Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999; 72: 60-64.
22. Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, et al., Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010; 34: 563-568.
23. Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y, Miura M,. The natural history of free cancer cells in the peritoneal cavity. Recent Results Cancer Res 2007; 169: 11-23.
24. Miyashiro I, Takachi K, Doki Y, Ishikawa O, Ohigashi H, Murata K, et al., When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant? World J Surg 2005; 29: 1131-1134. (Pubitemid 41618712)
25. Lorenzen S, Panzram B, Rosenberg R, Nekarda H, Becker K, Schenk U, et al., Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol 2010; 17: 2733-2739.
26. Kodera Y, Ito S, Mochizuki Y, Kondo K, Koshikawa K, Suzuki N, et al.,; Chubu Clinical Oncology Group. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol 2009; 35: 1158-1163.
27. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al.,; ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820. (Pubitemid 350044801)
28. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ,; Dutch Gastric Cancer Group. Value of palliative resection in gastric cancer. Br J Surg 2002; 89: 1438-1443.
29. Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM,. Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa. J Surg Oncol 2010; 102: 737-741.
30. Park SR, Kim MJ, Ryu KW, Lee JH, Lee JS, Nam BH, et al., Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg 2010; 251: 428-435.
31. Lee SE, Ryu KW, Nam BH, Lee JH, Choi IJ, Kook MC, et al., Prognostic significance of intraoperatively estimated surgical stage in curatively resected gastric cancer patients. J Am Coll Surg 2009; 209: 461-467.
32. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, et al., Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006; 32: 661-655.
33. Kim JY, Bae HS,. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer 2001; 4: 27-33.